SlideShare a Scribd company logo
Quality Risk Management

          Basic
Risk Management Facilitation
         Methods
   Presentation complied by Drug Regulations – a not for
     profit organization from publicly available material
     form FDA , EDQM . WHO and similar organizations.
       Visit www.drugregulations.org for the latest in
                       Pharmaceuticals.



                                www.drugregulations.org     1
   Flowchart
   Check Sheets
   Process mapping
   Cause and Effect Diagrams (Ishikawa / fish bone)

They might be helpful to support risk identification




                                www.drugregulations.org   2
Flowcharts



     Start

    Activity
                                Pictorial
    Activity
                                 representations
                                 of a process
   Decision    No   Action

      Yes                       Breaking the process
    Result                       down into its
                                 constituent steps

                                 www.drugregulations.org   3
Check sheets




                  Present information
                   in an efficient, clear
                   format

                  May be accomplished
                   with a simple listing of
                   items


                   www.drugregulations.org    4
Process mapping

   The indicators may be selected based on unit
    operations
   Shows how they are interrelated
Potential Areas of Use(s) / outcomes
   Provides a clear and simple visual representation
    of involved steps
   Facilitates understanding, explaining and
    systematically analyzing complex processes and
    associated risks
   A pre-requisite for the use of some other tools
                                                         ICH Q9
                               www.drugregulations.org            5
Ai
       Dispensing
                                                                                     r
                    Scale                Sieving                                     Fluidized
                                                                                     Bed Dryer
                                                   Granulation        Air


   Process                                        Magnesium
                                                    Stearate
                                                                                Blendin
                                                                                g
    mapping                   Sieving




                            Tabletting
                                                                                          Packagin
                                                                                             g
                                                          Coating

                                                      www.drugregulations.org                        6
Cause and Effect Diagrams (Ishikawa / fish bone)

Environment   People    Materials


                                                          Problem
                                                         statement


   Equipment Measurement      Methods
               System

                               www.drugregulations.org          7
Cause and Effect Diagrams (Ishikawa / fish bone)

   To associate multiple possible causes with a single effect
   Constructed to identify and organize possible causes for it
   Primary branch:     represents the effect
   Major branch:       corresponds to a major cause
   Minor branch:       correspond to more detailed causal
    factors




                                       www.drugregulations.org   8
Cause and Effect Diagrams (Ishikawa / fish bone)

How to perform?
 Define and agree a precise problem statement
  (put as “head” of fish bone) Think “What could be
  its causes?” for each node
 Add it to the “fish bone” diagram
 For each line pursue back to its root cause
 Consider splitting up overcrowded sections
  “bones”
 Consider which potential root
  causes and the need for
                                            Environment     People   Materials



  further investigation on them                                                       Problem
                                                                                     statement


                                                Equipment    Measurement
                                                               System      Methods
Cause and Effect Diagrams (Ishikawa / fish bone)




                            www.drugregulations.org   10
Coating                               Drying                         Milling                Analytical
                            Temperature

  Spray Rate             Redrying

    Pan Speed                      Time        Temp
                                     Milling
    Gun Distance                                    RH                     Screen Size                    Other

       Temperature                                Air Flow                       Porosity                Sampling

Atomizing Air Pressure                          Shock Cycle                      Mill Speed                 Method
                                                                                                                             Tablet
                                                                                             Drug
                                                                                                                            Hardness
    Operator             Precompressing                               Water              Substance
   Temp/RH         Main Compressing                                 Binder                    Age
                                                                                         P.S.
 Operator            Feeder Speed                                   Temp         Process Conditions
                                                                                                LOD

                                                                                                                          Cause and
Training              Press Speed                        Spray Rate
               Punch Penetration
                                                    Spray Pattern
                                                                                     HPMC
                                                                                                                      
                                                                                                                          Effect
                        Depth
                                                                             Methoxyl
                      Tooling                                P.S.
                                                                              Hydroxyl

                                                                                                                          Diagram
   Plant              Feed                                                          P.S.
                                                 Scrape Down
  Factors            Frame                                                            LOD

                     Compressing
                                           Chopper Speed                     Other
                                                                                                                          for Tablet
                                                                                                                          Hardness
                                               Mixer Speed            Syloid
                                                                        Lactose
                                Endpoint                                                     Raw
                                                                           Coating
                                                                                            Materials
                                   Power
                                                 Granulation
                                      Time
                                                                                                www.drugregulations.org                11

More Related Content

What's hot

Quality risk management
Quality risk managementQuality risk management
Quality risk management
imran bakshi
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
Sandhya Ganapathiraju
 
CDER
CDERCDER
Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment
Pharmaceutical
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical Industry
Mahesh shinde
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
Vaishali Dandge
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
shravan dubey
 
ICH Q10
ICH Q10ICH Q10
Corrective action preventive action (capa)
Corrective action preventive action (capa)Corrective action preventive action (capa)
Corrective action preventive action (capa)
tanvikumbhar
 
ICH Guideline – Q9
ICH Guideline – Q9ICH Guideline – Q9
ICH Guideline – Q9
rx_sonali
 
Self inspection
Self inspectionSelf inspection
Self inspection
Bangaluru
 
cGMP.
cGMP.cGMP.
Deviation QA
Deviation QADeviation QA
Deviation QA
prashik shimpi
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
AMOGH DANDEKAR
 
Audits in pharma industries
Audits in pharma industriesAudits in pharma industries
Audits in pharma industries
Nikita Amane
 
Various techniques for study of Crystal Properties
Various techniques for study of Crystal PropertiesVarious techniques for study of Crystal Properties
Various techniques for study of Crystal Properties
Cooling Crystal
 
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
Dr Ajay Kumar Tiwari
 
Corrective Action & Preventive Action
Corrective Action & Preventive ActionCorrective Action & Preventive Action
Corrective Action & Preventive Action
GMP EDUCATION : Not for Profit Organization
 
Current good manufacturing practice
Current good manufacturing practiceCurrent good manufacturing practice
Current good manufacturing practice
Dr Subodh Satheesh
 

What's hot (20)

Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
CDER
CDERCDER
CDER
 
Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment Pharmaceutical Quality Risk Assessment
Pharmaceutical Quality Risk Assessment
 
Risk management in pharmaceutical Industry
Risk management in pharmaceutical IndustryRisk management in pharmaceutical Industry
Risk management in pharmaceutical Industry
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
 
Process validation
Process validationProcess validation
Process validation
 
Out of specification shravan
Out of specification shravanOut of specification shravan
Out of specification shravan
 
ICH Q10
ICH Q10ICH Q10
ICH Q10
 
Corrective action preventive action (capa)
Corrective action preventive action (capa)Corrective action preventive action (capa)
Corrective action preventive action (capa)
 
ICH Guideline – Q9
ICH Guideline – Q9ICH Guideline – Q9
ICH Guideline – Q9
 
Self inspection
Self inspectionSelf inspection
Self inspection
 
cGMP.
cGMP.cGMP.
cGMP.
 
Deviation QA
Deviation QADeviation QA
Deviation QA
 
Change control oos oot
Change control oos ootChange control oos oot
Change control oos oot
 
Audits in pharma industries
Audits in pharma industriesAudits in pharma industries
Audits in pharma industries
 
Various techniques for study of Crystal Properties
Various techniques for study of Crystal PropertiesVarious techniques for study of Crystal Properties
Various techniques for study of Crystal Properties
 
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
QUALITY MANAGEMNT SYSTEMS: Change Control (CC)
 
Corrective Action & Preventive Action
Corrective Action & Preventive ActionCorrective Action & Preventive Action
Corrective Action & Preventive Action
 
Current good manufacturing practice
Current good manufacturing practiceCurrent good manufacturing practice
Current good manufacturing practice
 

Viewers also liked

Quality Risk management Application of FMEA
Quality Risk management  Application of FMEAQuality Risk management  Application of FMEA
Quality Risk management Application of FMEA
GMP EDUCATION : Not for Profit Organization
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
muna_ali
 
Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
GMP EDUCATION : Not for Profit Organization
 
Risk management using FMEA in pharma
Risk management using FMEA in pharmaRisk management using FMEA in pharma
Risk management using FMEA in pharma
Sandeep Naik
 
Failure Mode Effect Analysis (FMEA)
Failure Mode Effect Analysis (FMEA)Failure Mode Effect Analysis (FMEA)
Failure Mode Effect Analysis (FMEA)
DEEPAK SAHOO
 
Who Guidance on Quality Risk Management
Who Guidance on Quality Risk ManagementWho Guidance on Quality Risk Management
Who Guidance on Quality Risk Management
GMP EDUCATION : Not for Profit Organization
 
Application of Quality Risk Management in Commissioning & Qualifcation
Application of Quality Risk Management in Commissioning & QualifcationApplication of Quality Risk Management in Commissioning & Qualifcation
Application of Quality Risk Management in Commissioning & Qualifcation
GMP EDUCATION : Not for Profit Organization
 
FMEA failure-mode-and-effect-analysis_Occupational safety and health
FMEA failure-mode-and-effect-analysis_Occupational safety and healthFMEA failure-mode-and-effect-analysis_Occupational safety and health
FMEA failure-mode-and-effect-analysis_Occupational safety and health
Jing Jing Cheng
 
Process fmea
Process fmea Process fmea
Process fmea
Cardiff City FC
 
FMEA Introduction.ppt
FMEA Introduction.pptFMEA Introduction.ppt
FMEA Introduction.ppt
bowerj
 
Introduction to Risk Management
Introduction to Risk ManagementIntroduction to Risk Management
Introduction to Risk Management
FAA Safety Team Central Florida
 
Fmea presentation
Fmea presentationFmea presentation
Fmea presentationMurat Terzi
 
Fmea
FmeaFmea
Application of Q R M in Manufacturing Operations
Application of Q R M in Manufacturing Operations Application of Q R M in Manufacturing Operations
Application of Q R M in Manufacturing Operations
GMP EDUCATION : Not for Profit Organization
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
Digital-360
 
Risk Analysis and Management
Risk Analysis and ManagementRisk Analysis and Management
Risk Analysis and Management
Genie
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
praveen dubey
 
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...Shivang Chaudhary
 

Viewers also liked (20)

Quality Risk management Application of FMEA
Quality Risk management  Application of FMEAQuality Risk management  Application of FMEA
Quality Risk management Application of FMEA
 
ICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk ManagementICH Guideline Q9 - Quality Risk Management
ICH Guideline Q9 - Quality Risk Management
 
Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
 
Risk management using FMEA in pharma
Risk management using FMEA in pharmaRisk management using FMEA in pharma
Risk management using FMEA in pharma
 
Failure Mode Effect Analysis (FMEA)
Failure Mode Effect Analysis (FMEA)Failure Mode Effect Analysis (FMEA)
Failure Mode Effect Analysis (FMEA)
 
Who Guidance on Quality Risk Management
Who Guidance on Quality Risk ManagementWho Guidance on Quality Risk Management
Who Guidance on Quality Risk Management
 
Application of Quality Risk Management in Commissioning & Qualifcation
Application of Quality Risk Management in Commissioning & QualifcationApplication of Quality Risk Management in Commissioning & Qualifcation
Application of Quality Risk Management in Commissioning & Qualifcation
 
FMEA failure-mode-and-effect-analysis_Occupational safety and health
FMEA failure-mode-and-effect-analysis_Occupational safety and healthFMEA failure-mode-and-effect-analysis_Occupational safety and health
FMEA failure-mode-and-effect-analysis_Occupational safety and health
 
FMEA Presentation
FMEA PresentationFMEA Presentation
FMEA Presentation
 
Process fmea
Process fmea Process fmea
Process fmea
 
FMEA Introduction.ppt
FMEA Introduction.pptFMEA Introduction.ppt
FMEA Introduction.ppt
 
Introduction to Risk Management
Introduction to Risk ManagementIntroduction to Risk Management
Introduction to Risk Management
 
Fmea presentation
Fmea presentationFmea presentation
Fmea presentation
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
Fmea
FmeaFmea
Fmea
 
Application of Q R M in Manufacturing Operations
Application of Q R M in Manufacturing Operations Application of Q R M in Manufacturing Operations
Application of Q R M in Manufacturing Operations
 
Quality Risk Management
Quality Risk ManagementQuality Risk Management
Quality Risk Management
 
Risk Analysis and Management
Risk Analysis and ManagementRisk Analysis and Management
Risk Analysis and Management
 
Quality risk management
Quality risk managementQuality risk management
Quality risk management
 
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
FMEA, DoE & PAT : Three Inseparable Organs of Quality Risk Management (QRM) B...
 

More from GMP EDUCATION : Not for Profit Organization

Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
GMP EDUCATION : Not for Profit Organization
 
New WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method ValidationNew WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method Validation
GMP EDUCATION : Not for Profit Organization
 
Blend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way ForwardBlend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way Forward
GMP EDUCATION : Not for Profit Organization
 
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
GMP EDUCATION : Not for Profit Organization
 
WHO Guidance on Preparation of Laboratory Information File
WHO  Guidance on Preparation of Laboratory Information FileWHO  Guidance on Preparation of Laboratory Information File
WHO Guidance on Preparation of Laboratory Information File
GMP EDUCATION : Not for Profit Organization
 
US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
GMP EDUCATION : Not for Profit Organization
 
Calculation of Risk Priority Numbar
Calculation of  Risk Priority NumbarCalculation of  Risk Priority Numbar
Calculation of Risk Priority Numbar
GMP EDUCATION : Not for Profit Organization
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
GMP EDUCATION : Not for Profit Organization
 
New WHO Guidance on CS Validation
New WHO Guidance on CS ValidationNew WHO Guidance on CS Validation
New WHO Guidance on CS Validation
GMP EDUCATION : Not for Profit Organization
 
New WHO Guidance on Process Validation
New WHO Guidance on Process ValidationNew WHO Guidance on Process Validation
New WHO Guidance on Process Validation
GMP EDUCATION : Not for Profit Organization
 
ASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and QualificationsASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and Qualifications
GMP EDUCATION : Not for Profit Organization
 
US FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ BatchesUS FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ Batches
GMP EDUCATION : Not for Profit Organization
 
Presentation on US FDA Data Integrity Guidance.
Presentation on US FDA  Data Integrity Guidance.Presentation on US FDA  Data Integrity Guidance.
Presentation on US FDA Data Integrity Guidance.
GMP EDUCATION : Not for Profit Organization
 
Quality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental MonitoringQuality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental Monitoring
GMP EDUCATION : Not for Profit Organization
 
Understanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room ContaminationUnderstanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room Contamination
GMP EDUCATION : Not for Profit Organization
 
Process Validation of Legacy Products
Process Validation of Legacy ProductsProcess Validation of Legacy Products
Process Validation of Legacy Products
GMP EDUCATION : Not for Profit Organization
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
GMP EDUCATION : Not for Profit Organization
 
Who Guidelines for Preparing SMF
Who Guidelines for Preparing  SMFWho Guidelines for Preparing  SMF
Who Guidelines for Preparing SMF
GMP EDUCATION : Not for Profit Organization
 
Validation of Microbiological Methods
Validation of Microbiological MethodsValidation of Microbiological Methods
Validation of Microbiological Methods
GMP EDUCATION : Not for Profit Organization
 
Presentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QPPresentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QP
GMP EDUCATION : Not for Profit Organization
 

More from GMP EDUCATION : Not for Profit Organization (20)

Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
 
New WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method ValidationNew WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method Validation
 
Blend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way ForwardBlend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way Forward
 
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
 
WHO Guidance on Preparation of Laboratory Information File
WHO  Guidance on Preparation of Laboratory Information FileWHO  Guidance on Preparation of Laboratory Information File
WHO Guidance on Preparation of Laboratory Information File
 
US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
 
Calculation of Risk Priority Numbar
Calculation of  Risk Priority NumbarCalculation of  Risk Priority Numbar
Calculation of Risk Priority Numbar
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
 
New WHO Guidance on CS Validation
New WHO Guidance on CS ValidationNew WHO Guidance on CS Validation
New WHO Guidance on CS Validation
 
New WHO Guidance on Process Validation
New WHO Guidance on Process ValidationNew WHO Guidance on Process Validation
New WHO Guidance on Process Validation
 
ASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and QualificationsASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and Qualifications
 
US FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ BatchesUS FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ Batches
 
Presentation on US FDA Data Integrity Guidance.
Presentation on US FDA  Data Integrity Guidance.Presentation on US FDA  Data Integrity Guidance.
Presentation on US FDA Data Integrity Guidance.
 
Quality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental MonitoringQuality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental Monitoring
 
Understanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room ContaminationUnderstanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room Contamination
 
Process Validation of Legacy Products
Process Validation of Legacy ProductsProcess Validation of Legacy Products
Process Validation of Legacy Products
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
 
Who Guidelines for Preparing SMF
Who Guidelines for Preparing  SMFWho Guidelines for Preparing  SMF
Who Guidelines for Preparing SMF
 
Validation of Microbiological Methods
Validation of Microbiological MethodsValidation of Microbiological Methods
Validation of Microbiological Methods
 
Presentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QPPresentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QP
 

Recently uploaded

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 

Recently uploaded (20)

BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 

Quality risk managment basic facilitation methods

  • 1. Quality Risk Management Basic Risk Management Facilitation Methods Presentation complied by Drug Regulations – a not for profit organization from publicly available material form FDA , EDQM . WHO and similar organizations. Visit www.drugregulations.org for the latest in Pharmaceuticals. www.drugregulations.org 1
  • 2. Flowchart  Check Sheets  Process mapping  Cause and Effect Diagrams (Ishikawa / fish bone) They might be helpful to support risk identification www.drugregulations.org 2
  • 3. Flowcharts Start Activity  Pictorial Activity representations of a process Decision No Action Yes  Breaking the process Result down into its constituent steps www.drugregulations.org 3
  • 4. Check sheets  Present information in an efficient, clear format  May be accomplished with a simple listing of items www.drugregulations.org 4
  • 5. Process mapping  The indicators may be selected based on unit operations  Shows how they are interrelated Potential Areas of Use(s) / outcomes  Provides a clear and simple visual representation of involved steps  Facilitates understanding, explaining and systematically analyzing complex processes and associated risks  A pre-requisite for the use of some other tools ICH Q9 www.drugregulations.org 5
  • 6. Ai Dispensing r Scale Sieving Fluidized Bed Dryer Granulation Air  Process Magnesium Stearate Blendin g mapping Sieving Tabletting Packagin g Coating www.drugregulations.org 6
  • 7. Cause and Effect Diagrams (Ishikawa / fish bone) Environment People Materials Problem statement Equipment Measurement Methods System www.drugregulations.org 7
  • 8. Cause and Effect Diagrams (Ishikawa / fish bone)  To associate multiple possible causes with a single effect  Constructed to identify and organize possible causes for it  Primary branch: represents the effect  Major branch: corresponds to a major cause  Minor branch: correspond to more detailed causal factors www.drugregulations.org 8
  • 9. Cause and Effect Diagrams (Ishikawa / fish bone) How to perform?  Define and agree a precise problem statement (put as “head” of fish bone) Think “What could be its causes?” for each node  Add it to the “fish bone” diagram  For each line pursue back to its root cause  Consider splitting up overcrowded sections “bones”  Consider which potential root causes and the need for Environment People Materials further investigation on them Problem statement Equipment Measurement System Methods
  • 10. Cause and Effect Diagrams (Ishikawa / fish bone) www.drugregulations.org 10
  • 11. Coating Drying Milling Analytical Temperature Spray Rate Redrying Pan Speed Time Temp Milling Gun Distance RH Screen Size Other Temperature Air Flow Porosity Sampling Atomizing Air Pressure Shock Cycle Mill Speed Method Tablet Drug Hardness Operator Precompressing Water Substance Temp/RH Main Compressing Binder Age P.S. Operator Feeder Speed Temp Process Conditions LOD Cause and Training Press Speed Spray Rate Punch Penetration Spray Pattern HPMC  Effect Depth Methoxyl Tooling P.S. Hydroxyl Diagram Plant Feed P.S. Scrape Down Factors Frame LOD Compressing Chopper Speed Other for Tablet Hardness Mixer Speed Syloid Lactose Endpoint Raw Coating Materials Power Granulation Time www.drugregulations.org 11